Arth by Emcure, a wellness brand from Emcure Pharmaceuticals, recently launched a new social awareness campaign called "Fight Against Obesity." The initiative began in late July 2026 and aims to change how India discusses obesity, moving away from judgment towards inspiration and awareness. This effort addresses India's growing public health challenge of rising obesity rates across the country.[pharmabiz+3]
India's Significant Obesity Challenge
Obesity is a major health concern in India. Recent data from the National Family Health Survey (NFHS) shows that about 30 percent of women and 27 percent of men in India are overweight or obese.Beyond physical health issues, obesity can also affect a person's confidence, relationships, career opportunities, and overall quality of life.India faces a significant obesity crisis, with nearly 254 million people living with generalized obesity and an additional 351 million facing abdominal obesity.[pharmabiz+8]
The "Fight Against Obesity" Initiative
The "Fight Against Obesity" campaign seeks to simplify conversations around weight management. It plans to bring together leading doctors, health experts, and physically fit individuals. These experts will share practical insights, help correct common myths, and provide clear information about obesity, nutrition, metabolism, and how to manage weight in a lasting way.The campaign will use short, 30-second videos led by experts to promote science-backed awareness about obesity.The initiative also plans to educate school children across India and will conclude with an annual conference and awards program.[pharmabiz+5]
Namita Thapar, founder of Arth by Emcure, spoke about the new campaign. "Obesity is a global challenge, and Arth is committed to this cause," she said.Thapar added that she is personally interviewing top doctors in the country to help educate people and make a difference.She also mentioned that the education will be delivered through 30-second videos, making it "fun and not preachy."[pharmabiz+8]
The "Fight Against Obesity" initiative receives support from Arth's product, Bitter Drops. This pre-meal supplement contains 14 natural bitter herbs. It helps reduce food cravings and supports overall weight management efforts.[pharmabiz+2]
Emcure's Broader Commitment to Weight Management
Emcure Pharmaceuticals, the parent company of Arth by Emcure, has also been active in addressing obesity. In December 2025, Emcure launched Poviztra, a semaglutide injection for weight loss, across India.This made Emcure the first Indian company to exclusively distribute and commercialize Novo Nordisk's second brand of semaglutide for weight management.Poviztra is available in a once-weekly pen device in five different strengths.[m+5]
The semaglutide injection is prescribed alongside a reduced-calorie diet and increased physical activity. It is for adults with a body mass index (BMI) of 30 kg/m² or higher, or 27 kg/m² or higher if they have at least one weight-related health condition such as high blood pressure or type 2 diabetes. In clinical trials, this semaglutide formulation helped many patients achieve more than 20% weight loss.[m+1]
To make the treatment more accessible, Emcure Pharmaceuticals announced a significant price reduction for Poviztra in April 2026. The cost was lowered by up to 55 percent, making semaglutide therapy more affordable for patients nationwide. The starting dose, which was previously priced at Rs 8,790 per month for four weekly doses, is now available for Rs 3,999 per month. This price change aims to improve patient access to long-term therapy and encourage better treatment adherence.[emcure+4]
Satish Mehta, CEO and Managing Director of Emcure Pharmaceuticals Ltd., highlighted the urgency of the situation. "India is facing a significant obesity crisis," Mehta said. He added that introducing Poviztra is an important step in making scientifically proven weight-management solutions more widely available.[medboundhub+1]
Additional Emcure Initiatives
Emcure Pharmaceuticals has also launched other public awareness campaigns. In December 2025, the company introduced "Winning Over Obesity," a digital campaign featuring cricketer MS Dhoni. This campaign, themed MAHI – MAKING A HEALTHIER INDIA, aims to shift public understanding of obesity as a chronic health condition. It encourages individuals to take steps towards long-term health. Thecampaign is supported by WinningOverObesity.com, a website offering resources and guidance on weight management.[expresspharma+2]
Beyond these initiatives, Arth by Emcure also offers other wellness products, such as its "Arth Weight Management" supplement. This supplement contains 1500 mg of L-Carnitine Tartrate, which helps support fat metabolism, energy levels, and endurance when combined with a balanced diet and regular exercise.[expresspharma]
Moving Forward
With the "Fight Against Obesity" campaign and its broader efforts, Emcure Pharmaceuticals and its wellness brand Arth are working to raise awareness, provide education, and offer solutions for India's growing obesity challenge. These initiatives aim to encourage healthier lifestyle choices and support individuals in their journey toward better health.
